October 2022 Drug Utilization Review Board Meeting Summary

The Texas Drug Utilization Review Board met Friday, October 21, to make recommendations about clinical prior authorizations and drugs on the Texas Medicaid Preferred Drug List. A summary of the meeting is now available.

Other news

CGRP Antagonist Prophylaxis Prior Authorization Revisions Scheduled for November 22
Annual Performance Report for the Prescription Drug Rebate Program published

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website.

Stay Connected
					(en español)

Subscriber Services
Manage Preferences | Unsubscribe | Help


This email was sent to [email protected] using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202